Events & Presentations

Date	Title
Nov 20, 2024 4:00 AM EST	Jefferies London Healthcare Conference Click here for Webcast Add to Outlook Add to Google Calendar
Dec 8, 2024 5:00 PM EST	Updated Data in Multiple Myeloma and First Data in non-Hodgkin’s Lymphoma from the Ongoing Phase 1/2 Trial of Cemsidomide Presented at ASH 2024 Click here for Webcast Add to Outlook Add to Google Calendar

Date	Title
Sep 18, 2024 8:35 AM EDT	2024 Cantor Global Healthcare Conference Click here for Webcast
Sep 13, 2024 12:00 PM EDT	Preliminary Monotherapy Results from the Ongoing Phase 1 Trial of CFT1946 Presented at ESMO Congress Click here for Webcast
Sep 5, 2024 8:45 AM EDT	Wells Fargo Healthcare Conference 2024 Click here for Webcast
Jul 15, 2024 12:00 PM EDT	UBS Targeted Protein Degradation Day Click here for webcast:
Apr 16, 2024 10:30 AM EDT	Stifel 2024 Targeted Oncology Forum Click here for Webcast

Date	Title
October 31, 2024	Corporate Presentation – October 2024
October 30, 2024	TPD Summit - Preliminary Monotherapy Data from the Ongoing Phase 1 Trial of CFT1946, a BRAF V600 Mutant Degrader, for Solid Tumors
September 13, 2024	CFT1946 Monotherapy Results from the Ongoing Phase 1 Trial
September 13, 2024	ESMO 2024 – CFT1946 Phase 1 Monotherapy Dose Escalation
April 8, 2024	AACR 2024: CFT1946 in Preclinical Models of BRAF V600X Melanoma, CRC, NSCLC, and Brain Metastasis

Upcoming Events